PTC-derived ATCs are characterized by BRAF and TERT promoter mutations, which occur prior to anaplastic transformation, and ATCs harboring TERT promoter mutation are at higher risk for anaplastic transformation [18]. The gene discussed is BRAF; the disease is Ehlers-Danlos syndrome, musculocontractural type.